Baccharin from Brazilian green propolis induces neurotrophic signaling pathways in PC12 cells: potential for axonal and synaptic regeneration

• Published in: Naunyn-Schmiedeberg's archives of pharmacology Vol. 395; no. 6; pp. 659 - 672
• Main Authors: do Amaral, Lilian, Caldas, Gabriel Rocha, dos Santos, Neife Aparecida Guinaim, Parreira, Renato Luis Tame, Bastos, Jairo Kennup, dos Santos, Antonio Cardozo
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-06-2022; Springer Nature B.V
• Subjects: 1-Phosphatidylinositol 3-kinase; AKT protein; Animals; Axonal plasticity; Axonogenesis; Biomedical and Life Sciences; Biomedicine; Blood-brain barrier; Brazil; Cell activation; Dendritic branching; GAP-43 protein; GAP-43 Protein - metabolism; MAP kinase; Metabolic pathways; Nerve growth factor; Nerve Growth Factor - metabolism; Nerve Growth Factor - pharmacology; Neurodegeneration; Neurodegenerative diseases; Neuroprotection; Neurosciences; Neurotrophic factors; Original Article; PC12 Cells; Pharmacokinetics; Pharmacology/Toxicology; Pheochromocytoma cells; Phosphatidylinositol 3-Kinases - metabolism; Physicochemical properties; Propolis; Propolis - pharmacology; Proto-Oncogene Proteins c-akt - metabolism; Rats; Receptor, trkA - metabolism; Regeneration; Signal Transduction; Structure-function relationships; Synapsin I; Synapsins - metabolism; Trichothecenes; TrkA protein; TrkA receptors; Brazil; Neuroprotection; Neuritogenesis; Neurodegeneration; Synaptic plasticity; Axonal plasticity; Baccharin; Brazilian green propolis
• DOI: 10.1007/s00210-022-02224-4
• EISSN: 1432-1912
• ISSN: 0028-1298

Neurodegenerative diseases are characterized by progressive loss of the structure and function of specific neuronal populations, and have been associated with reduced neurotrophic support. Neurotrophins, like NGF (nerve growth factor), are endogenous proteins that induce neuritogenesis and modulate axonal growth, branching, and synapsis; however, their therapeutic application is limited mainly by low stability, short half-life, and inability to cross the blood–brain barrier (BBB). Small neurotrophic molecules that have suitable pharmacokinetics and are able to cross the BBB are potential candidates for neuroprotection. Baccharin is a bioactive small molecule isolated from Brazilian green propolis. In the present study, we investigated the neurotrophic and neuroprotective potential of baccharin in the PC12 cell neuronal model. We used pharmacological inhibitors (K252a, LY294002, and U0126), and ELISA (phospho-trkA, phospho-Akt, and phospho-MEK) to investigate the involvement of trkA receptor, PI3k/Akt pathway, and MAPK/Erk pathway, respectively. Additionally, we evaluated the expression of axonal (GAP-43) and synaptic (synapsin I) proteins by western blot. The results showed that baccharin induces neuritogenesis in NGF-deprived PC12 cells, through activation of trkA receptor and the downstream signaling cascades (PI3K/Akt and MAPK/ERK), which is the same neurotrophic pathway activated by NGF in PC12 cells and neurons. Baccharin also induced the expression of GAP-43 and synapsin I, which mediate axonal and synaptic plasticity, respectively. Additionally, in silico predictions of baccharin showed favorable physicochemical properties, pharmacokinetics, drug-likeness, and medicinal chemistry friendliness
.
Altogether, these findings suggest that baccharin is a promising neurotrophic agent whose therapeutic application in neurodegeneration should be further investigated.